UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

0703 LOW DOSE OF ARIPIPRAZOLE REDUCED NOCTURNAL SLEEP TIME IN THE PATIENTS WITH DELAYED SLEEP PHASE DISORDER AND DEPRESSIVE SYMPTOMS

Sleep (New York, N.Y.), 2017-04, Vol.40 (suppl_1), p.A260-A261

2017

Volltextzugriff (PDF)

0944 SUPERFICIAL WHITE MATTER AND CORTICAL THICKNESS ASSOCIATED WITH PARASOMNIAS IN CHILDREN

Sleep (New York, N.Y.), 2017-04, Vol.40 (suppl_1), p.A351-A351

2017

Volltextzugriff (PDF)

1- O-, 2- O- and 3- O- β-glycosyl- sn-glycerols: Structure - anti-tumor-promoting activity relationship

Bioorganic & medicinal chemistry letters, 1996-05, Vol.6 (10), p.1187-1190

1996

Volltextzugriff (PDF)

1004PSYMPTOM PREVALENCE AND FUNCTIONAL STATUS AMONG PATIENTS WITH ADVANCED CANCERS OF THE HEAD AND NECK

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv346-iv346

2014

Volltextzugriff (PDF)

103Maximum calcium thickness is a useful predictor for under expansion after post dilatation in calcified lesions: optical coherence tomographic study

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

10P Safety and tolerability of first-line (1L) osimertinib (osi) ± platinum-pemetrexed in EGFRm advanced NSCLC: Data from FLAURA2

ESMO open, 2024-03, Vol.9, p.102589, Article 102589

2024

Volltextzugriff (PDF)

1115P Amivantamab vs real-world (RW) therapies for advanced non-small cell lung cancer (aNSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutation (E20i) in Japan

Annals of oncology, 2022-09, Vol.33, p.S1061

2022

Volltextzugriff (PDF)

1259O A randomized phase II study of osimertinib with or without bevacizumab in advanced lung adenocarcinoma patients with EGFR T790M mutation (West Japan Oncology Group 8715L)

Annals of oncology, 2020-09, Vol.31, p.S813-S814

2020

Volltextzugriff (PDF)

1315MO Durable efficacy of zenocutuzumab, a HER2 x HER3 bispecific antibody, in advanced NRG1 fusion-positive (NRG1+) non-small cell lung cancer (NSCLC)

Annals of oncology, 2023-10, Vol.34, p.S756-S757

2023

Volltextzugriff (PDF)

132P The potential of VEGF-A in the peripheral blood serum as a biomarker of response in the addition of bevacizumab with chemotherapy-combined immunotherapy for metastatic nonsquamous non-small cell lung cancer

Annals of oncology, 2024-09, Vol.35, p.S268-S269

2024

Volltextzugriff (PDF)

1481O - Clinical development of molecular-targeted therapies for non-small cell lung cancer through nationwide genome screening in Japan (LC-SCRUM-Japan)

Annals of oncology, 2019-10, Vol.30, p.v604-v604

2019

Volltextzugriff (PDF)

1481OClinical development of molecular-targeted therapies for non-small cell lung cancer through nationwide genome screening in Japan (LC-SCRUM-Japan)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

16-kda prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway

Cancer research (Chicago, Ill.), 2005-09, Vol.65 (17), p.7984-7992

2005

Volltextzugriff (PDF)

192 Clinicopathologic, genomic and immunophenotypic features and outcomes to immune checkpoint inhibitors in patients with mucinous lung adenocarcinoma

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A219-A220

2023

Volltextzugriff (PDF)

The first-ilk superparticle in second-order lagrangian and backgrounds

Physics letters. B, 1991-08, Vol.265 (3), p.278-286

1991

Volltextzugriff (PDF)

[(2-Phenylindol-3-yl)methylene]propanedinitriles inhibit the growth of breast cancer cells by cell cycle arrest in G(2)/M phase and apoptosis

Bioorganic & medicinal chemistry, 2007-12, Vol.15 (23), p.7368-7379

2007

Volltextzugriff (PDF)

[(2-Phenylindol-3-yl)methylene]propanedinitriles inhibit the growth of breast cancer cells by cell cycle arrest in G 2/M phase and apoptosis

Bioorganic & medicinal chemistry, 2007, Vol.15 (23), p.7368-7379

2007

Volltextzugriff (PDF)

[(2-Phenylindol-3-yl)methylene]propanedinitriles inhibit the growth of breast cancer cells by cell cycle arrest in G2/M phase and apoptosis

Bioorganic & medicinal chemistry, 2007-12, Vol.15 (23), p.7368-7379

2007

Volltextzugriff (PDF)

205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies Part II 28–30 March 2014, Naarden, The Netherlands

Neuromuscular disorders : NMD, 2015-03, Vol.25 (3), p.268-272

2015

Volltextzugriff (PDF)

229P Clinicopathologic and genomic features of patients with mucinous lung adenocarcinoma and response to systemic therapies

ESMO open, 2024-03, Vol.9, p.102879, Article 102879

2024

Volltextzugriff (PDF)

237th ENMC International Workshop: GNE myopathy – current and future research Hoofddorp, The Netherlands, 14–16 September 2018

Neuromuscular disorders : NMD, 2019-05, Vol.29 (5), p.401-410

2019

Volltextzugriff (PDF)

3-dimensional adaptive raw-data filter: evaluation in low dose chest multidetector-row computed tomography

Journal of computer assisted tomography, 2006-11, Vol.30 (6), p.933-938

2006

Volltextzugriff (PDF)

3 mm band line survey toward the high-velocity compact cloud CO−0.40−0.22

Proceedings of the International Astronomical Union, 2013-10, Vol.9 (S303), p.202-204

2013

Volltextzugriff (PDF)

1 – 25 von 1.910

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.608)
Mit Volltextzugriff
(1.675)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.237)
Life Sciences & Biomedicine
(659)
Humans
(464)
Biological And Medical Sciences
(330)
Technology
(324)
Physical Sciences
(321)
Female
(315)
Male
(293)
Animals
(258)
Medical Sciences
(255)
Physics
(216)
Materials Science
(202)
Materials Science, Multidisciplinary
(171)
Exact Sciences And Technology
(164)
Middle Aged
(157)
Adult
(132)
Aged
(129)
Neurosciences & Neurology
(125)
Mice
(123)
Oncology
(96)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(10)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

0703 LOW DOSE OF ARIPIPRAZOLE REDUCED NOCTURNAL SLEEP TIME IN THE PATIENTS WITH DELAYED SLEEP PHASE DISORDER AND DEPRESSIVE SYMPTOMS

0944 SUPERFICIAL WHITE MATTER AND CORTICAL THICKNESS ASSOCIATED WITH PARASOMNIAS IN CHILDREN

1- O-, 2- O- and 3- O- β-glycosyl- sn-glycerols: Structure - anti-tumor-promoting activity relationship

1004PSYMPTOM PREVALENCE AND FUNCTIONAL STATUS AMONG PATIENTS WITH ADVANCED CANCERS OF THE HEAD AND NECK

103Maximum calcium thickness is a useful predictor for under expansion after post dilatation in calcified lesions: optical coherence tomographic study

10P Safety and tolerability of first-line (1L) osimertinib (osi) ± platinum-pemetrexed in EGFRm advanced NSCLC: Data from FLAURA2

1115P Amivantamab vs real-world (RW) therapies for advanced non-small cell lung cancer (aNSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutation (E20i) in Japan

1259O A randomized phase II study of osimertinib with or without bevacizumab in advanced lung adenocarcinoma patients with EGFR T790M mutation (West Japan Oncology Group 8715L)

1315MO Durable efficacy of zenocutuzumab, a HER2 x HER3 bispecific antibody, in advanced NRG1 fusion-positive (NRG1+) non-small cell lung cancer (NSCLC)

132P The potential of VEGF-A in the peripheral blood serum as a biomarker of response in the addition of bevacizumab with chemotherapy-combined immunotherapy for metastatic nonsquamous non-small cell lung cancer

1481O - Clinical development of molecular-targeted therapies for non-small cell lung cancer through nationwide genome screening in Japan (LC-SCRUM-Japan)

1481OClinical development of molecular-targeted therapies for non-small cell lung cancer through nationwide genome screening in Japan (LC-SCRUM-Japan)

16-kda prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway

192 Clinicopathologic, genomic and immunophenotypic features and outcomes to immune checkpoint inhibitors in patients with mucinous lung adenocarcinoma

The first-ilk superparticle in second-order lagrangian and backgrounds

[(2-Phenylindol-3-yl)methylene]propanedinitriles inhibit the growth of breast cancer cells by cell cycle arrest in G(2)/M phase and apoptosis

[(2-Phenylindol-3-yl)methylene]propanedinitriles inhibit the growth of breast cancer cells by cell cycle arrest in G 2/M phase and apoptosis

[(2-Phenylindol-3-yl)methylene]propanedinitriles inhibit the growth of breast cancer cells by cell cycle arrest in G2/M phase and apoptosis

205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies Part II 28–30 March 2014, Naarden, The Netherlands

214th ENMC International Workshop: Establishing an international consortium for gene discovery and clinical research for Congenital Muscle Disease, Heemskerk, the Netherlands, 6–18 October 2015

229P Clinicopathologic and genomic features of patients with mucinous lung adenocarcinoma and response to systemic therapies

237th ENMC International Workshop: GNE myopathy – current and future research Hoofddorp, The Netherlands, 14–16 September 2018

272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16–18 June 2023, Hoofddorp, The Netherlands

3-dimensional adaptive raw-data filter: evaluation in low dose chest multidetector-row computed tomography

3 mm band line survey toward the high-velocity compact cloud CO−0.40−0.22

Suchergebnisse filtern